. Data are presented as the means ± SD, n = 5. * P < 0.05, ** P < 0.01 and *** P < 0.001 represent significant differences between the indicated columns. Figure 6 . New bone-like tissue around the Bio-Oss bone powder in immunocompromised mice through PDLSCs implantation with COL4A2 coated ECM. The P-dECM or TCP (no-ECM) were coated with COL4A2 peptide (0.5mg/ml). (A) H&E staining revealed that more bone-like tissue and inserting PDLlike fibers were observed in no-ECM + COL4A2 or P-dECM + COL4A2 than no-ECM or P-dECM groups respectively. Black arrow, the newly formed bone-like tissue. Green arrow, the newly formed vessels. Data are presented as the means ± SD, n = 6. * P < 0.05, ** P < 0.01 and *** P < 0.001 represent significant differences between the indicated columns.
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